Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Myobloc as effective as Botox says Solstice
Cervical dystonia, (spasmodic torticollis), is a focal dystonia in which patients experience the involuntary contraction of muscles in the neck, leading to abnormal movements and posture. Botox, produced
Cervical dystonia, (spasmodic torticollis), is a focal dystonia in which patients experience the involuntary contraction of muscles in the neck, leading to abnormal movements and posture. Botox, produced
A research team led by Riyi Shi has found that a chemical called acrolein, a known carcinogen, is present at high levels in spinal tissue for several days
The company is seeking approval to market Revlimid as a targeted treatment for transfusion-dependent patients with low to intermediate risk of myelodysplastic syndromes (MDS) with deletion 5q chromosomal
The public-private sector partnership will utilize promising new technology developed by Glaxo and facilitate early research and development of GSK’s non-human primate adenovirus vaccine vector as an enabling
The agreement with Xoma will initially focus on working towards a drug aimed at treating obesity, diabetes and metabolic diseases. Lexicon will select additional targets during the course
Intranasal Technology Inc (ITI) is working on the development of a number of new drug formulations and technologies for nasal delivery, including sedatives, anticonvulsants, and medications for migraine
The announcement comes after the company held discussions with the FDA to determin possible future designations for Erbitux. ImClone said it would conduct two clinical trails which would
Fodosine, which is being studied in a phase IIa clinical trial, is a transition state analog inhibitor which binds to the target enzyme. The fast track programs of
The new powder was submitted for regulatory review in Europe and the US on a country-by-country basis beginning in December 2002 and has now been approved in Switzerland,
Led by an investigator at the University of Minnesota, the study showed 75% of patients treated with Aldara Cream three times per week, and nearly 60% treated two